| # | Drug | Count |
|---|---|---|
| 0 | PALBOCICLIB | 62 |
| 1 | LETROZOLE | 57 |
| 2 | RIBOCICLIB | 57 |
| 3 | FULVESTRANT | 53 |
| 4 | LETROZOLE TABLETS | 45 |
| 5 | EXEMESTANE | 27 |
| 6 | CAPECITABINE | 25 |
| 7 | DENOSUMAB | 24 |
| 8 | ANASTROZOLE | 22 |
| 9 | ANASTROZOLE TABLETS | 20 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZINGIBER OFFICINALE | 3 | 0.0345 |
| 1 | FERROUS FUMARATE AND POLYSACCHRIDE IRON COMPLEX AND FOLIC ACID | 1 | 0.0104 |
| 2 | DEMECLOCYCLINE | 1 | 0.0044 |
| 3 | PAMIDRONATE DISODIUM | 10 | 0.0029 |
| 4 | BODY CLEANSER | 2 | 0.0028 |
| 5 | RIBOCICLIB | 57 | 0.0017 |
| 6 | FULVESTRANT | 53 | 0.0016 |
| 7 | ELACESTRANT | 11 | 0.0015 |
| 8 | ADO-TRASTUZUMAB EMTANSINE | 11 | 0.0013 |
| 9 | EXEMESTANE | 27 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 115 |
| 1 | Aromatase Inhibitor [EPC] | 80 |
| 2 | Estrogen Receptor Antagonist [EPC] | 64 |
| 3 | Benzodiazepine [EPC] | 29 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 28 |
| 5 | RANK Ligand Inhibitor [EPC] | 24 |
| 6 | HER2/neu Receptor Antagonist [EPC] | 21 |
| 7 | Dihydropyridine Calcium Channel Blocker [EPC] | 20 |
| 8 | Calcium Channel Blocker [EPC] | 19 |
| 9 | Corticosteroid [EPC] | 19 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen Receptor Antagonist [EPC] | 64 | 0.0016 |
| 1 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 17 | 0.0008 |
| 2 | Aromatase Inhibitor [EPC] | 80 | 0.0007 |
| 3 | Provitamin D2 Compound [EPC] | 17 | 0.0006 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 5 | HER2/neu Receptor Antagonist [EPC] | 21 | 0.0003 |
| 6 | Kinase Inhibitor [EPC] | 115 | 0.0002 |
| 7 | Non-Standardized Plant Allergenic Extract [EPC] | 3 | 0.0002 |
| 8 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 9 | Potassium-sparing Diuretic [EPC] | 2 | 0.0001 |